RT Journal Article
SR Electronic
T1 Cross-Sectional Study of University students’ attitudes to ‘on campus’ delivery of COVID-19 vaccines and future-proofing MenACWY and MMR vaccination rates by adopting COVID-19 vaccine roll-out strategies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.07.22270394
DO 10.1101/2022.02.07.22270394
A1 Webb, Adam
A1 Gogoi, Mayuri
A1 Weidman, Sarah
A1 Woolf, Katherine
A1 Zavala, Maria
A1 Ladhani, Shamez N
A1 Pareek, Manish
A1 Gies, Lieve
A1 Bayliss, Christopher D
YR 2022
UL http://medrxiv.org/content/early/2022/02/07/2022.02.07.22270394.abstract
AB Background University students are a critical group for vaccination programmes against COVID-19, meningococcal disease (MenACWY), and measles, mumps and rubella (MMR). We aimed to evaluate risk factors for vaccine hesitancy (refusal or intention to refuse a vaccine) and views of university students about on-campus vaccine delivery.Methods Cross-sectional anonymous online questionnaire study of undergraduate students at a British university in June 2021. Chi-squared, Fisher’s exact, univariate and multivariate tests were applied to detect associations.Results Complete data were obtained from 827 participants (7.6% response-rate). Two-thirds (64%; 527/827) reported having been vaccinated against COVID-19 and a further 23% (194/827) agreed to be vaccinated. Other responses were either unclear (66) or indicated an intention to refuse vaccination (40). Hesitancy for COVID-19 vaccines was 5% (40/761). COVID-19 vaccine hesitancy was associated with black ethnicity (aOR, 7.01, 95% CI, 1.8-27.3) and concerns about vaccine side-effects (aOR, 1.72; 95% CI, 1.23-2.39). Lower levels of vaccine hesitancy were detected amongst students living in private accommodation (aOR, 0.13; 95% CI, 0.04-0.38) compared to those living at home. Uncertainty about their personal vaccine status was frequently observed for MMR (11%) and MenACWY (26%) vaccines. Campus-associated COVID-19 vaccine campaigns were definitely (45%) or somewhat (16%) favoured by UK-based students and more so among UK-based international students (62% and 12%, respectively).Conclusions Vaccine hesitancy among students of black ethnicity and those living at home requires further exploration because attitudes in these groups may affect COVID-19 vaccine uptake. High levels of uncertainty among students about their MMR and MenACWY vaccine status are also a concern for the effectiveness of these vaccine programmes. This issue could be tackled by extending the capabilities of digital platforms for accessing vaccine information, such as the NHSapp in the UK. Sector-wide implementation of on-campus vaccine delivery may also improve vaccine uptake, especially for international students.Competing Interest StatementManish Pareek reports payments from Qiagen for teaching purposes. Katherine Woolf reports consulting fees from the Federation of the Royal Colleges of Physicians UK that were paid to her institution. All other authors report no competing interests.Funding StatementThis work was supported by a Time Critical COVID-19 grant (ES/W00299X/1) from the Economic and Social Research Council (to CB, LG, and MP), by a MRC-UK Research and Innovation and NIHR, entitled UK-REACH, (MR/V027549/1) award (to MP) and an NIHR Development and Skills Enhancement Award (to MP).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for this work was given by the University of Leicester (UoL) Medicine and Biological Sciences Research Ethics Committee (reference number 29522).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://reshare.ukdataservice.ac.uk/855372/ https://reshare.ukdataservice.ac.uk/855372/